Antithrombotic Therapy and Device-Related Thrombosis Following Endovascular Left Atrial Appendage Closure

Jacqueline Saw1, Jens Erik Nielsen-Kudsk2, Martin Bergmann3

  • 1Division of Cardiology, Vancouver General Hospital, Vancouver, British Columbia, Canada.

Insights

Antithrombotic therapy after left atrial appendage closure (LAAC) is crucial for stroke prevention. Device-related thrombosis is a risk, necessitating careful management and surveillance post-LAAC.

Area of Science:

  • Cardiology
  • Medical Devices
  • Thrombosis Research

Background:

  • Left atrial appendage closure (LAAC) is a growing procedure for stroke prevention in nonvalvular atrial fibrillation patients.
  • It is particularly important for individuals unable to tolerate or ineligible for oral anticoagulation.
  • Understanding post-procedural management is key to optimizing outcomes.

Purpose of the Study:

  • To review current evidence on antithrombotic therapy following LAAC.
  • To assess the risk of device-related thrombosis (DRT) after LAAC.
  • To discuss therapeutic options and rationale for antithrombotic strategies post-LAAC.

Main Methods:

  • Systematic review of existing literature on antithrombotic therapy and DRT after LAAC.
  • Analysis of current clinical practices and physician-dependent choices in antithrombotic regimens.
  • Evaluation of patient-specific bleeding risk factors influencing therapeutic decisions.

Main Results:

  • Device-related thrombosis is a significant complication of LAAC, with unclear etiology.
  • Real-world data suggests dual-antiplatelet therapy or direct oral anticoagulation may be comparable to warfarin and aspirin for safety and DRT occurrence.
  • Routine device imaging surveillance is recommended to detect DRT, which requires aggressive treatment due to high thromboembolic risks.

Conclusions:

  • There are uncertainties and dilemmas regarding optimal antithrombotic therapy post-LAAC.
  • The study provides an in-depth discussion on available options and the rationale for their use.
  • Aggressive management of diagnosed DRT is essential to mitigate thromboembolic risks.
Abstract

Related Concept Videos

Surface Appendages of Archaea01:23

Surface Appendages of Archaea

Archaeal surface appendages are highly specialized structures essential for environmental adaptation, encompassing roles in adhesion, biofilm formation, and motility. Among these appendages, pili and archaella stand out for their distinct morphologies and functionalities, enabling archaea to thrive in diverse and often extreme environments.Pili: Adhesion and Biofilm FormationPili are filamentous structures assembled from pilin protein subunits, primarily contributing to adhesion and biofilm...
623
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
429
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.2K
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.4K
Group Therapy01:26

Group Therapy

Group therapy is a sociocultural approach to psychological treatment, where individuals with shared psychological challenges come together under the guidance of a mental health professional. This therapeutic modality offers unique opportunities for individuals to connect, share, and grow within the context of a supportive group. By fostering mutual understanding and collaboration, group therapy can address a range of psychological concerns effectively, often complementing or surpassing the...
391
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
297